'Dlbcl' presentation slideshows

Dlbcl - PowerPoint PPT Presentation

LATEST CONCEPTS IN LARGE CELL AND HODGKIN LYMPHOMAS

LATEST CONCEPTS IN LARGE CELL AND HODGKIN LYMPHOMAS

LATEST CONCEPTS IN LARGE CELL AND HODGKIN LYMPHOMAS. Morton Coleman, M.D. Director, Center for Lymphoma and Myeloma New York-Presbyterian Hospital Weill Cornell Medical Center Clinical Professor of Medicine Weill Cornell Medical College Chairman, Medical Affiliates Board

★ ★ ★ ★ ★

834 views • 67 slides
LATEST CONCEPTS IN LARGE CELL AND HODGKIN LYMPHOMAS

LATEST CONCEPTS IN LARGE CELL AND HODGKIN LYMPHOMAS

LATEST CONCEPTS IN LARGE CELL AND HODGKIN LYMPHOMAS. Morton Coleman, M.D. Director, Center for Lymphoma and Myeloma New York-Presbyterian Hospital Weill Cornell Medical Center Clinical Professor of Medicine Weill Cornell Medical College Chairman, Medical Affiliates Board

★ ★ ★ ★ ★

852 views • 67 slides
Diagnostically and Prognostically Significant Genetic Alterations in Diffuse Large B-Cell Lymphoma

Diagnostically and Prognostically Significant Genetic Alterations in Diffuse Large B-Cell Lymphoma

Diagnostically and Prognostically Significant Genetic Alterations in Diffuse Large B-Cell Lymphoma. Friederike Kreisel, MD Department of Pathology and Immunology Washington University in St. Louis. Frequency of B-and T-Cell Lymphomas. 8.6%. 11.7%. 2.5%. 33%. 6.0%. 6.7%. 9.4%. 22.1%.

★ ★ ★ ★ ★

798 views • 52 slides
Diagnostically and Prognostically Significant Genetic Alterations in Diffuse Large B-Cell Lymphoma

Diagnostically and Prognostically Significant Genetic Alterations in Diffuse Large B-Cell Lymphoma

Diagnostically and Prognostically Significant Genetic Alterations in Diffuse Large B-Cell Lymphoma. Friederike Kreisel, MD Department of Pathology and Immunology Washington University in St. Louis. Frequency of B-and T-Cell Lymphomas. 8.6%. 11.7%. 2.5%. 33%. 6.0%. 6.7%. 9.4%. 22.1%.

★ ★ ★ ★ ★

853 views • 52 slides
Francisco Hernandez-Ilizaliturri MD Farhana Malik MBBS Myron Czuczman MD

Francisco Hernandez-Ilizaliturri MD Farhana Malik MBBS Myron Czuczman MD

Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) with Non-Germinal center B-cell Phenotype is associated with a Higher response to Lenalidomide (L) or in Combination with Rituximab(R). Francisco Hernandez-Ilizaliturri MD Farhana Malik MBBS Myron Czuczman MD.

★ ★ ★ ★ ★

618 views • 43 slides
Follicular Lymphoma: A retrospective study ( 68 cases)

Follicular Lymphoma: A retrospective study ( 68 cases)

Follicular Lymphoma: A retrospective study ( 68 cases). M. BENDARI, M. Rachid, S. Marouane , A. Quessar , S. Benchekroun Department of Hematology-Oncology pediatric Hospital 20 Aout , CHU Ibn Rochd Casablanca . Background.

★ ★ ★ ★ ★

424 views • 39 slides
Germinal Centers and Lymphomagenesis

Germinal Centers and Lymphomagenesis

V(D)J Recombination. IgV hypermutation. Immature B-cells. Germinal Center B-cells. Memory B-cells. Ag. B-CLL. Plasma cells. Bone Marrow. Mantle. Germinal Center. ALL. MCL. BL FL DLBCL. MM. Apoptosis. Germinal Centers and Lymphomagenesis.

★ ★ ★ ★ ★

1.74k views • 32 slides
Wilson WH et al. Proc ASH 2012;Abstract 686.

Wilson WH et al. Proc ASH 2012;Abstract 686.

The Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib (PCI-32765), Has Preferential Activity in the ABC Subtype of Relapsed/Refractory De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Interim Results of a Multicenter, Open-Label, Phase 2 Study. Wilson WH et al. Proc ASH 2012;Abstract 686.

★ ★ ★ ★ ★

292 views • 10 slides
Goals

Goals

Goals. Goal #1 : Are there differentially expressed (DE) genes unique to follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL)? Goal #2 : Can we use those genes to distinguish between these two subtypes? Goal #3 : Is the classification generalizable across different datasets?

★ ★ ★ ★ ★

263 views • 10 slides
Utility of Post-Therapy Surveillance Scans in Diffuse Large B-Cell Lymphoma

Utility of Post-Therapy Surveillance Scans in Diffuse Large B-Cell Lymphoma

Utility of Post-Therapy Surveillance Scans in Diffuse Large B-Cell Lymphoma. Thompson C et al. Proc ASCO 2013;Abstract 8504. Background. Diffuse large B-cell lymphoma (DLBCL) is an aggressive lymphoma that is potentially curable even after relapse.

★ ★ ★ ★ ★

230 views • 10 slides
DLBCL and IOL

DLBCL and IOL

Supplementary Material Figure S2. IL-10. IL-6. (1610). # #. (pg/ml). (pg/ml). (1280). (264). (647). (167). 200. (75). (51). 150. 30. 100. 50. 20. 0. 10. DLBCL and IOL. Other PCNSL. DLBCL and IOL. Other PCNSL. 0. sIL-2R. b 2-M. (U/ml). ( m g/L). (3495). (978).

★ ★ ★ ★ ★

145 views • 1 slides

View Dlbcl PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Dlbcl PowerPoint presentations. You can view or download Dlbcl presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.